2 Bromo alpha ergocryptine,
2 Bromo alpha ergokryptine,
2 Bromoergocryptine,
2 Bromoergocryptine Mesylate,
2 Bromoergocryptine Methanesulfonate,
2 Bromoergokryptine,
2-Bromo-alpha-ergocryptine,
2-Bromo-alpha-ergokryptine,
2-Bromoergocryptine,
2-Bromoergocryptine Mesylate,
2-Bromoergocryptine Methanesulfonate,
2-Bromoergokryptine,
Bromocriptin,
Bromocriptine,
Bromocriptine Mesylate,
Bromocryptin,
CB 154,
CB-154,
CB154,
Mesylate, 2-Bromoergocryptine,
Mesylate, Bromocriptine,
Methanesulfonate, 2-Bromoergocryptine,
Parlodel,
BROMOCRIPTINE MESYLATE,
Bromocriptine mesilate,
Bromocryptine mesylate,
Pravidel,
Parlodel,
Bagren,
22260-51-1,
Bromergon,
CB-154 mesylate,
UNII-FFP983J3OD,
2-Bromo-alpha-ergocryptine mesylate,
Bromocriptine methanesulfonate,
Bromocryptine methanesulfonate,
CB 154,
Bromocriptine (mesylate),
EINECS 244-881-1,
FFP983J3OD,
2-Bromo-alpha-ergocryptine methanesulfonate,
CHEBI:3182,
2-Bromine-alpha-ergocryptine methanesulfonate,
2-Bromo-alpha-ergokryptine-mesilate [German],
CB-154,
2-Bromoergocryptine monomethanesulfonate (salt),
(+)-Bromocriptine methanesulfonate,
2-Bromoergocryptine,
alpha-Ergocryptine, 2-bromo-, methanesulfonate,
2-Bromo-12'-hydroxy-5'alpha-isobutyl-2'-isopropylergotaman-3',6',18-trione monomethanesulphonate,
Cycloset,
oline-9-carboxamide methanesulfonate,
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, monomethanesulfonate (salt), (5'alpha)-,
NSC169774,
2-Bromoergocryptine Mesylate,
SR-01000597796,
Bromocriptine mesylate [USAN],
SR-01000075356,
C32H40BrN5O5.CH4O3S,
Bromocriptine mesylate [USAN:USP],
Parlodel (TN),
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman methanesulfonate (salt),
(6aR,9R)-5-Bromo-N-[(2R,5S,10aS,10bS)-10b-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quin,
2-Bromo-alpha-ergokryptine-mesilate,
Prestwick_771,
CAS-22260-51-1,
AC1L1KXP,
DSSTox_CID_197,
DSSTox_RID_75426,
DSSTox_GSID_20197,
SCHEMBL40559,
Bromocriptine mesylate (USP),
Bromocriptine mesilate (JP17),
CHEMBL1200503,
DTXSID6020197,
CB 154 methanesulfonate (salt),
2-Bromo |A-Ergocryptine Mesylate,
NOJMTMIRQRDZMT-GSPXQYRGSA-N,
HMS1568I04,
HMS3260D03,
HMS3675K09,
HMS3712I04,
2-Bromo alpha-Ergocryptine Mesylate,
Tox21_303597,
Tox21_500171,
HY-12705A,
.alpha.-Ergocryptine, methanesulfonate,
AKOS015896276,
CCG-220121,
CCG-221475,
CS-6048,
LP00171,
LS-7234,
NSC-169774,
NCGC00257268-01,
NCGC00260856-01,
AN-17214,
2-Bromo-a-ergocryptine methanesulfonate salt,
B6298,
EU-0100171,
B 2134,
D00780,
2-Bromo-.alpha.-ergocryptine monomethanesulfonate,
93201-EP2272825A2,
93201-EP2305633A1,
I06-2158,
SR-01000075356-1,
SR-01000597796-1,
SR-01000597796-2,
(5 inverted exclamation mark |A)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione Methanesulfonate,
(5'a)-2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione mesylate,
(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman methanesulfonate,
(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate,
(5xi,5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman methanesulfonate (salt),
(5xi,5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman methanesulfonate (salt),
CID31100,
CS-I-00026,
C32-H4O-Br-N5-O5.C-H4-O3-S,
Ergocryptine, 2-bromo-, monomethanesulfonate (salt),
2-Bromo-alpha-ergocryptine methanesulfonate salt, 98% - 100mg 100mg,
Ergotaman-3', 6',18-triona, 2-bromo-12'-hidroxi-2'-(1-metiletil)-5-(2-metilpropil)-, (5alfa)-, Metanosulfonato ( 01:01),
Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-, monomethanesulfonate (salt),